Curanex Pharmaceuticals Inc CURX
4.80 USD -0.87 (-15.34%)
Regular-session close
4.79 -0.01 -0.21%
After hours · Nov 13, 4:00 PM ET
4.59 Day range 4.82
3.66 52-week range 11.06
- YTD
- -27.49%
- 1 year
- -56.60%
- Market cap
- 7.53M
- EPS (ttm)
- -7.80
- YTD return
- -27.49%
- 1-year return
- -56.60%
- Volume
- 6.30K
- Avg volume
- 21.67K
- Open
- 4.82
- Previous close
- 5.67
- Day's range
- 4.59 – 4.82
- 52-week range
- 3.66 – 11.06
5D -0.66 (-10.71%)
Financials — quick view
CURX Revenue — quarterly 0
CURX Net income — quarterly -2.82M
CURX EPS — quarterly -1.86
News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - 12 Health Care Stocks Moving In Monday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) 
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) 
Curanex Pharmaceuticals Q1 EPS $(0.11) Down From $(0.01) YoY - Curanex Continues To Advance Phyto-N As Lead Development Candidate, With Ulcerative Colitis As Initial Target Indication; Co. Prepares Phyto-N For Planned IND Submission In Q4 Of 2026
Your note
Sign in to keep a note on CURX — it syncs with the Stock Master app.